Subject    :    [2017 Apr;41(2)] Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
Writer KDA
Date 2017-07-06 11:01:54 Hit 6,258

Diabetes Metab J. 2017 Apr;41(2):128-134. English.
Published online Jan 11, 2017. 
Copyright © 2017 Korean Diabetes Association
Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
Sabitha Palazhy, and Vijay Viswanathan
M.V. Hospital for Diabetes & Prof. M. Viswanathan Diabetes Research Centre, Chennai, India.

Corresponding author: Sabitha Palazhy. M.V. Hospital for Diabetes & Prof. M. Viswanathan Diabetes Research Centre, No. 4, West Madha Church St, Royapuram, Chennai 600013, India. Email: 
Received April 06, 2016; Accepted November 07, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.



Diabetic nephropathy is a major complication of diabetes and an established risk factor for cardiovascular events. Lipid abnormalities occur in patients with diabetic nephropathy, which further increase their risk for cardiovascular events. We compared the degree of dyslipidemia among type 2 diabetes mellitus (T2DM) subjects with and without nephropathy and analyzed the factors associated with nephropathy among them.


In this retrospective study, T2DM patients with overt nephropathy were enrolled in the study group (n=89) and without nephropathy were enrolled in the control group (n=92). Both groups were matched for age and duration of diabetes. Data on total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), urea and creatinine were collected from the case sheets. TG/HDL-C ratio, a surrogate marker for small, dense, LDL particles (sdLDL) and estimated glomerular filtration rate (eGFR) were calculated using equations. Multivariate analysis was done to determine the factors associated with eGFR.


Dyslipidemia was present among 56.52% of control subjects and 75.28% of nephropathy subjects (P=0.012). The percentage of subjects with atherogenic dyslipidemia (high TG+low HDL-C+sdLDL) was 14.13 among controls and 14.61 among nephropathy subjects. Though serum creatinine was not significantly different, mean eGFR value was significantly lower among nephropathy patients (P=0.002). Upon multivariate analysis, it was found that TC (P=0.007) and HDL-C (P=0.06) were associated with eGFR among our study subjects.


Our results show that dyslipidemia was highly prevalent among subjects with nephropathy. Regular screening for dyslipidemia may be beneficial in controlling the risk for adverse events among diabetic nephropathy patients.

Cardiovascular risk; Diabetic nephropathy; Dyslipidemia; Small, dense low density lipoprotein

Articles - Reviews in DMJ
No. Subject Date Hit ↓
197 [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 6,672
196 [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 6,649
195 [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 6,515
194 [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 6,195
193 [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 6,327
192 [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 6,408
191 [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 6,299
190 [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 5,974
189 [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 5,920
188 [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 6,273


Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.